Sclerosing cholangitis in the paediatric patient

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 4, 2001, Pages 681-690

  Mieli Vergani, Giorgina ^a   Vergani, Diego ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmunity; Children; Chronic liver disease; Immunodeficiency; Sclerosing cholangitis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD DISEASE; CHOLANGIOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEMALE; HISTIOCYTOSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; LIVER TRANSPLANTATION; MALE; PRIMARY SCLEROSING CHOLANGITIS; PSORIASIS; RETICULOSARCOMA; SCLEROSING CHOLANGITIS; SICKLE CELL ANEMIA;

EID: 0034879312     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2001.0213     Document Type: Article

References (46)

1. Sclerosing cholangitis in children
2. Primary sclerosing cholangitis in 32 children: Clinical, laboratory and radiographic features with survival analysis
3. Primary sclerosing cholangitis in childhood
4. Primary sclerosing cholangitis in children: Study of five cases and review of the literature
5. Primary sclerosing cholangitis in children
6. Sclerosing cholangitis in childhood: A 17-year experience
7. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases
8. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis
9. A 39 year old with chronic hepatitis
10. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis
11. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study
12. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
13. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood
14. Alcohol dehydrogenase: A target of humoral autoimmune response in liver disease
15. Autoantibodies to soluble liver antigen/UGA suppressor tRNA-associated antigenic protein are specific to autoimmune liver disease
16. Immunogenetics of liver disease
17. Autoimmune hepatitis in childhood: A 20-year experience
18. Frequency and nature of the variant syndromes of autoimmune liver disease
19. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial
20. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis
21. Ursodiol for primary sclerosing cholangitis
22. Fibrosing pancreatitis associated with pericholangitis and cholangitis in a child
23. Sclerosing cholangitis with neonatal onset
24. Neonatal sclerosing cholangitis in 2 siblings: A category of progressive intrahepatic cholestasis
25. Cholangiopathy and tumors of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM
26. Paediatric sclerosing cholangitis associated with primary immunodeficiency
27. Clinical spectrum of X-linked hyper-IgM syndrome
28. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with a congenital immunodeficiency disorder
29. Hematopoietic stem cell transplantation for primary lymphoid immunodeficiencies
30. Engraftment of allogeneic hematopoetic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
31. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
32. Correction of hyper-IgM syndrome following liver and bone marrow transplantation
33. Langerhans cell histiocytosis (histiocytosis X): A clonal proliferative disease
34. Langerhans cell histiocytosis
35. Clinical aspects of Langerhans cell histiocytosis
36. Langerhans cell histiocytosis pathobiology and pathogenesis
37. Obstructive jaundice in children with histiocytosis X
38. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993
39. Sclerosing cholangitis and histiocytosis X
40. Pretreatment liver biopsy in 20 children with histiocytosis X: A clinicopathologic correlation
41. Liver transplantation in patients with Langerhans' cell histiocytosis
42. Liver transplantation in Langerhans' cell histiocytosis (histiocytosis X)
43. Successful orthotopic liver transplantation in a child with Langerhans cell histiocytosis
44. Successful orthotopic transplantation in two patients with liver failure due to sclerosing cholangitis with Langerhans cell histiocytosis
45. Liver transplantation for Langerhans' cell histiocytosis and immunomodulation of disease pre- and posttransplant
46. Pediatric liver transplantation for Langerhans' cell histiocytosis